🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Our amazing colleague and resident MacArthur genius ⁦⁦Victor J. Torres⁩ fighting the good fight against drug resistant Staphylococcus aureus. cell.com/cell-host-micr…

Excited to host our first jr. faculty candidate for the Virology Institute of NYU (The VIRION) this Thursday. If you love virology and want to join a group of like-minded individuals, send me your CV and let me know. Doors open in 2024! #LoveVirology med.nyu.edu/departments-in…

I agree that only a few ISGs are responsible for the antiviral activity against a family of viruses, but the subset involved can differ dramatically. Mx for some, OAS for others, etc. The IFN system works by targeting many biologies simultaneously - only some of which will work.

events.columbia.edu/go/tom_maniati… Join us in this journey to the birth of molecular biology through the history of the one and only Tom Maniatis!!!

Our latest research with Vanna Zachariou sheds light on the neurological impacts of non-infectious #SARS-CoV-2 RNA deposition in the dorsal root ganglia - shedding light on a possible driver of #NeuroPASC. Amazing work by Alex Serafini, PhD/MHA and Justin Frere tinyurl.com/neuroPASC

Excited to join former Maniatis members in celebrating Tom's birthday at this event. Tom is an exceptional mentor, a champion for his trainees, and an amazing scientist. The world definitely needs more Toms to continue inspiring future generations of researchers.

Stay tuned for more #COVID insights informed by our hamster model including #COVIDToe and conditions that result in #SARSCoV2 viremia.

New study from the lab showing how a delayed IFN-I response enables #SARSCoV2 viremia, possibly explaining non-pulmonary symptomatology, including #LongCOVID. Beautiful work by Lucía Carrau et al. science.org/doi/10.1126/sc…

Looking to start (or move) a virology-based research program to NYC? Consider applying to the VIRION. We are looking for candidates interested in tool building, virus-host interactions, or fundamental virology. To apply, see tinyurl.com/VIRIONprofessor

Sometimes, the best defense against infection is a clever decoy. Kudos to my amazing colleague Ned The Landau Lab for his groundbreaking work on developing an ACE2 decoy as a therapeutic for all variants of #SARSCoV2. See write-up NIH tinyurl.com/NedsDecoys

It was an honor to be on Paul Rusling today with Marc Siegel MD. Thank you for the opportunity to discuss what I love the most - viruses. #LoveVirology @SiriusXM

Such a great meeting. A community of scientists who share a passion for RNA and virus biology. Beautiful science, thoughtful questions, and lots of informative discussions. #EMBOeukRNA23

Looking to establish your own virus-based research program? Apply to the Virology Institute of NYU. Appreciate all amazing CVs received so far. Interview invitations going out at the end of the month. Let's make groundbreaking viral research together! tinyurl.com/TheVIRIONAd

Thrilled to share our first collab with one of my many amazing NYU Langone Health colleagues, Jef Boeke, describing an innovative approach to create Genetically Engineered Mouse Models (GEMMs) used here to render mice naturally susceptible to #SARSCoV2. nature.com/articles/s4158…

While not cited, this group corroborated our published work showing that #LongCovid patients demonstrate a sustained interferon signature in the olfactory bulb (which can also be seen in the golden hamster model of long COVID). tinyurl.com/4s5uk84e vs rdcu.be/dyOTB

Introducing the newest member of team tenOever. Who knew high throughput robotic RNA sequencing could be so adorable.

Another win for gene therapy. Given the recent successes for the field in the last few years, I think the community should embrace these wins and stop focussing on the failures of the past. fda.gov/news-events/pr…

Love the cross-talk between development and innate defenses. Examples include antiviral RNAi being repurposed for developmental miRNA biology, or conversely, developmental TLRs being repurposed for defense. Now we see TLR9 also contributing to memory rdcu.be/dCHcO"

Curious how the scientific community feels about quality vs quantity as it relates to grant submissions. Given how a single reviewer's opinion can mean the difference between funded or not, which strategy is better? #GrantWriting #Research #Reviewer3isTheWorst

I’m pleased to announce my transition to Chair of the Department of Microbiology at NYU Grossman School of Medicine. As part of this role, we’re recruiting two junior faculty for 2025, focusing on infection biology. Learn more and apply: apply.interfolio.com/153243